Simple blood test could tell doctors if cancer treatment will work
NCT ID NCT07376512
Summary
This study aims to see if a blood test can predict which patients with advanced lung cancer or melanoma will respond to a common type of immunotherapy. Researchers will analyze tiny particles in the blood of 378 patients before and during their standard treatment. The goal is to find markers that help doctors choose the right treatment sooner, avoiding ineffective therapies for patients who won't benefit.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHU Besançon - Service Dermatologie
Besançon, 25000, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CHU Besançon - Service Pneumologie Oncologie Thoracique
Besançon, 25000, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CHU Dijon - Service Oncologie Médicale
Dijon, 21000, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Centre Georges-François Leclerc
Dijon, 21000, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Centre Leon Berard - Service Oncologie Médicale
Lyon, 69000, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.